Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baked Milk Oral Immunotherapy for Cow's Milk Allergy
NCT03462030Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Mar 2018
- Primary completion
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Cow's milk allergy (CMA) comparing Baked Milk OIT with Placebo (2 arms). Primary endpoint: Number of Participants With Treatment-related Adverse Events at 1 year. Started Mar 2018; status: completed.
02
Drugs
baked milk oral immunotherapy
03
Conditions
Cow's milk allergy (CMA)
Beyond the preview
Go deeper on NCT03462030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03462030.